APA (7th ed.) Citation

YH, L., CC, Y., SC, W., HW, S., YC, H., SY, L., . . . SW, K. (2025). A novel agent, p-toluenesulfonamide, in the management of malignant pleural effusions. Lung cancer (Amsterdam, Netherlands), 210, 108814. https://doi.org/10.1016/j.lungcan.2025.108814

Chicago Style (17th ed.) Citation

YH, Luo, et al. "A Novel Agent, P-toluenesulfonamide, in the Management of Malignant Pleural Effusions." Lung Cancer (Amsterdam, Netherlands) 210 (2025): 108814. https://doi.org/10.1016/j.lungcan.2025.108814.

MLA (9th ed.) Citation

YH, Luo, et al. "A Novel Agent, P-toluenesulfonamide, in the Management of Malignant Pleural Effusions." Lung Cancer (Amsterdam, Netherlands), vol. 210, 2025, p. 108814, https://doi.org/10.1016/j.lungcan.2025.108814.